Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer (Q81760737)

From Wikidata

Jump to navigation Jump to search

scientific article published on 09 August 2008

edit

Language	Label	Description	Also known as
English	Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer	scientific article published on 09 August 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

title

Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

main subject

apoptotic process

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

cell growth

1 reference

based on heuristic

inferred from title

author name string

K Nakamura

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

F Abarzua

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

A Hongo

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

J Kodama

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

Y Nasu

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

H Kumon

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

Y Hiramatsu

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

publication date

9 August 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

published in

Annals of Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

volume

20

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

page(s)

63-70

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

cites work

BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1128/MCB.19.12.8469

Identifiers

DOI

10.1093/ANNONC/MDN556

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

PubMed publication ID

18689863

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18689863

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18689863%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81760737&oldid=2165042367"